Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GammaStar Medical Group is a leading Chinese medical technology company specializing in the development and manufacture of advanced stereotactic radiotherapy systems. Founded in 1999, the company is best known for its proprietary rotating Gamma Knife technology, which is used for the non-invasive treatment of intracranial and body tumors. Beyond its flagship Gamma Knife systems, GammaStar provides a comprehensive range of oncology solutions, including linear accelerators and diagnostic imaging equipment such as PET-CT scanners. The company also operates a network of radiotherapy centers and provides technical support services across China. GammaStar has established a significant presence in the Asian market by making precision radiation oncology more accessible. It continues to innovate in the field of high-end medical equipment to improve cancer treatment outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GammaStar Medical Group.